Embecta Investor Suit Says Pen Needle Weakness Was Hidden
Medical device company Embecta Corp. and two of its executives were hit with a proposed class action Wednesday, alleging they misled investors about the sales performance of the company's pen needles,...To view the full article, register now.
Already a subscriber? Click here to view full article